Masimo | MASI - Pre Tax Profit


Masimo reported $71.3M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Accuray USD 3.23M 6.56M Dec/2024
Align Technology USD 148.89M 27.71M Mar/2026
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Avanos Medical USD 1.2M 2.4M Dec/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
General Electric Aerospace USD 2.2B 654M Mar/2026
Globus Medical USD 169.23M 25.24M Dec/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
Masimo USD 71.3M 3.6M Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Orthofix International USD -2.19M 20.07M Dec/2025
Owens Minor USD 35.71M 5.37M Sep/2025
ResMed USD 496.15M 13.77M Dec/2025
Steris USD 257.8M 66.6M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025